Medical titanium alloy, medical titanium alloy additive and preparation method of medical titanium alloy additive
By optimizing the composition and process of Ti-Ta-Nb-Zr alloy, combined with heat treatment and 3D printing technology, the problems of high elastic modulus and low corrosion resistance in the existing technology are solved, and the mechanical properties and resistance of medical titanium alloys are significantly improved. Corrosive, suitable for the preparation of a variety of medical additives.
Patent Information
- Application Number
- CN202410888138.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-04
- Publication Date
- 2024-11-08
AI Technical Summary
The existing medical Ti-Ta-Nb-Zr alloys have problems with high elastic modulus and low corrosion resistance during the preparation process, and defects such as pores and component segregation are common in 3D printing processes, resulting in poor mechanical properties.
By optimizing the alloy composition and process, the preparation method includes heat treatment after molding, specifically 750±10℃/8h/AC+200±10℃/12h/AC stabilization treatment, combined with appropriate powder making and 3D printing processes, Medical titanium alloy additives with low elastic modulus and high corrosion resistance were produced.
It significantly improves the tensile strength, bending strength and corrosion resistance of the material, reduces the elastic modulus, making the material more suitable for the manufacturing of medical titanium alloy additives, especially for dental implants and other applications.
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of medical additives, and more specifically, relates to a medical titanium alloy, a medical titanium alloy additive and a preparation method thereof. Background Art
[0002] Titanium and titanium alloys have the characteristics of low elastic modulus, non-toxicity, excellent corrosion resistance and biocompatibility, and are highly favored in the field of biomedical materials as medical additives. Ti-Ta-Nb-Zr (TTNZ) alloy, the elements it contains are non-biotoxic, among which Ta and Nb can significantly improve the corrosion resistance of the material, Ta can also reduce the coagulation effect of the material, increase its hydrophilicity and protein adsorption capacity, Nb promotes osteoblast adhesion and aggregation, and Zr has a certain inhibitory effect on Staphylococcus aureus, and has broad application prospects.
[0003] The as-TTNZ alloy disclosed in Chinese patent CN 110960725 A has raw material components of 14.5-16.5% Ta, 2.5-4.5% Nb, 2.2-4.2% Zr, 0-0.0005% O, and the rest is Ti. The alloy has a tensile strength of about 650MPa and an elastic modulus of more than 20GPa, but still has the defects of high elastic modulus and poor corrosion resistance. Chinese patent CN109332698A discloses TTNZ alloy powder, which includes at least the following mass fractions of each element: Ti>84%, Ta10%-10.9%, Nb1.45%-1.85%, Zr1.35%-1.85%. In the above two prior arts, the oral implant is prepared by laser selective melting additive manufacturing process without heat treatment, and there are many 3D printing defects, such as pores, component segregation, etc., resulting in low mechanical properties and corrosion resistance.
[0004] Therefore, the present invention proposes a medical titanium alloy with lower elastic modulus and ultra-high corrosion resistance by optimizing alloy composition and process. Summary of the invention
[0005] Based on the above-mentioned technical problems existing in the prior art, the purpose of the present invention is to provide medical titanium alloy, medical titanium alloy additive and preparation method thereof, which can effectively improve the tensile strength and corrosion resistance of medical titanium alloy and reduce its elastic modulus.
[0006] In order to achieve the above object, the technical solution of the present invention is as follows:
[0007] A medical titanium alloy, whose raw material components are: Ta 9.5-14.0%, Nb 1-5%, Zr 1-5%, O 0.005-0.05%, and the balance is Ti.
[0008] Furthermore, the raw material components are:
[0009] Ta 9.5-14.0%, Nb 1-3%, Zr 1-3%, O 0.005-0.02%, and the balance is Ti.
[0010] Furthermore, the raw material components are:
[0011] Ta 9.5-12.0%, Nb 1-2%, Zr 1-2%, O 0.005-0.01%, and the balance is Ti.
[0012] The above-mentioned method for preparing the medical titanium alloy at least includes heat treatment after forming.
[0013] Furthermore, the heat treatment is specifically 750±10°C / 8h / AC+200±10°C / 12h / AC stabilization treatment, wherein AC is air cooling.
[0014] The present invention also provides a medical titanium alloy additive material, which is obtained by powdering, 3D printing and heat treatment processes of the above-mentioned medical titanium alloy.
[0015] Furthermore, the medical titanium alloy additive can be a dental implant, a root-shaped implant, a bionic titanium mesh or a bone plate, as well as other medical devices, prostheses or artificial organs and auxiliary treatment equipment implanted in the human body.
[0016] The present invention also discloses a method for preparing the above-mentioned medical titanium alloy additive material, which is obtained by powdering, 3D printing and heat treatment of alloy raw materials; the powdering specifically includes:
[0017] After the billet for powdering is obtained by the method of melting the cast rod, the powder is obtained by PREP (plasma rotating electrode method) or EIGA (electrode induction gas atomization method).
[0018] Furthermore, when the EIGA method is used to prepare the powder, the process is as follows: output power density is 400±20% J / g, atomization pressure is 5±20% MPa, atomization flow rate is 900±20% Nm 3 / h process conditions to produce powder.
[0019] Furthermore, when the PREP method is used to prepare the powder, the powder making equipment uses a direct-connected high-speed motor to drive the rod, and non-transferred arc heating, and controls the atmosphere through a dynamic sealing method to produce the powder.
[0020] Furthermore, the powder is sieved through a 270-mesh sieve to obtain a powder that can be used for 3D printing, and the particle size distribution of the powder is 25≤D 50 ≤60μm, D 90 ≤100μm.
[0021] Furthermore, the 3D printing specifically includes: preparing by a laser selective melting method, wherein the laser power is 200±20% W, the scanning speed is 2000±20% mm / s, the scanning spacing is 0.03-0.08 mm, and the powder thickness is 0.03-0.08 mm to print out the alloy entity.
[0022] Furthermore, the heat treatment is specifically 750±10°C / 8h / AC+200±10°C / 12h / AC stabilization treatment, wherein AC is air cooling.
[0023] The Ti-Ta-Nb-Zr (TTNZ) alloy provided by the present invention has no biological toxicity in its contained elements, wherein Ta and Nb can significantly improve the corrosion resistance of the material, Ta can also reduce the coagulation effect of the material, increase its hydrophilicity and protein adsorption capacity, Nb has a promoting effect on the adhesion and aggregation of osteoblasts, and Zr has a certain inhibitory effect on Staphylococcus aureus, and has broad application prospects. The contents of Ta, Nb, Zr and O are optimized and designed, and combined with appropriate processing technology, the corrosion resistance of the material can be improved on the basis of ensuring good mechanical properties. Oxygen is an important component of the alloy. If the oxygen content is too high, it is easy to form coarse oxide inclusions; if the oxygen content is too low, generally the appropriate amount of oxygen interstitially solid-dissolved in the alloy matrix forms a diffusely distributed oxide phase with the alloying elements, which plays the role of pinning dislocations to strengthen the alloy. At the same time, this diffusely distributed oxide can also promote blood compatibility and improve impedance. The composition of Ta, Nb and Zr is timely, and the alloy matrix is composed of α+β two-phase structure. Combined with the optimized powder making process and 3D printing process, a dense blank is obtained. After stabilization treatment at 750±10℃ / 8h / AC+200±10℃ / 12h / AC, the 3D printing structure is improved, some defects such as pores are eliminated, the segregated components are homogenized, and the supersaturated solid solution forms a fine second phase to improve the performance of the material. The uniform and fine α+β two-phase structure is further optimized through stabilization treatment, which greatly improves the mechanical properties and corrosion resistance of the material and reduces the elastic modulus, making this method more suitable for the manufacture of medical titanium alloy additives.
[0024] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0025] The present invention reduces the amount of alloy elements, improves the mechanical properties of the alloy, reduces the elastic modulus, and the tensile strength, elongation after fracture, compressive elastic modulus and flexural strength are 715.4MPa, 25.7%, 18.1GPa and 1470MPa respectively, which is more suitable for the manufacture of medical titanium alloy additives. The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C are 106.1Ω·cm 2 and 4.738×10 5 Ω·cm2 , indicating that the alloy has good corrosion resistance and can be used in the preparation of dental implants. DETAILED DESCRIPTION
[0026] To make the purpose, technical scheme and advantages of the present invention clearer, the present invention will be described in further detail below in conjunction with embodiment, but the embodiments of the present invention are not limited thereto. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by the technicians belonging to the technical field of the present invention. The terms used in the specification of the present invention herein are only for the purpose of describing specific embodiments, and are not intended to limit the present invention. It should be noted that, unless otherwise specified, the reagents used in the present embodiment, etc. are all common commercial products.
[0027] Example 1
[0028] A medical titanium alloy, whose alloy composition is Ti-9.5Ta-5Nb-5Zr-0.05O, is prepared by EIGA method, and its output power density is 480J / g, atomization pressure is 4MPa, and atomization flow rate is 1080Nm 3 / h process, and the powder was obtained by sieving with 270 mesh. 50 and D 90 The alloy entity was printed by laser selective melting with a laser power of 240W, a scanning speed of 1600mm / s, a scanning interval of 0.03mm and a powder thickness of 0.08mm; the material was obtained after treatment at 750±10℃ / 8h / AC+200±10℃ / 12h / AC. Its tensile strength, elongation after fracture, compressive elastic modulus and flexural strength are 715.4MPa, 25.7%, 18.1GPa and 1470MPa respectively, and the density reaches 4.86g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 106.1Ω·cm 2 and 4.738×10 5 Ω·cm 2 , indicating that the alloy has good corrosion resistance.
[0029] Example 2
[0030] A medical titanium alloy, the alloy composition of which is Ti-14Ta-1Nb-1Zr-0.005O, the powder is prepared by EIGA method, the output power density is 360J / g, the atomization pressure is 6MPa, and the atomization flow rate is 720Nm 3 / h process, and the powder was obtained by sieving through -270 mesh. 50 and D 90The alloy solid was printed by laser selective melting with a laser power of 160W, a scanning speed of 2400mm / s, a scanning interval of 0.08mm and a powder thickness of 0.03mm; the material was obtained after treatment at 750±10℃ / 8h / AC+200±10℃ / 12h / AC. The tensile strength, elongation after fracture, compressive elastic modulus and flexural strength of the material before heat treatment were 596.4MPa, 17.5%, 28.4GPa and 892MPa respectively, and the density reached 4.80g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 85.7Ω·cm 2 and 1.336×10 5 Ω·cm 2 The tensile strength, elongation after fracture, compressive elastic modulus and flexural strength of the heat-treated material are 703.2MPa, 27.3%, 12.6GPa and 1340MPa respectively, and the density reaches 4.81g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 105.3Ω·cm 2 and 4.139×10 5 Ω·cm 2 , indicating that the alloy has good corrosion resistance.
[0031] Example 3
[0032] A medical titanium alloy, whose alloy composition is Ti-10Ta-1.5Nb-1.5Zr-0.01O, and whose preparation method is the same as that of Example 1. Its tensile strength, elongation after fracture, compressive elastic modulus and flexural strength are 726.5MPa, 28.1%, 11.6GPa and 1452MPa respectively, and its density reaches 4.86g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 153.4Ω·cm 2 and 7.365×10 5 Ω·cm 2 , indicating that the alloy has good corrosion resistance.
[0033] Example 4
[0034] A medical titanium alloy, the alloy composition of which is Ti-10Ta-1.5Nb-1.5Zr-0.01O, is prepared by a PREP method, the powder making equipment adopts a direct-connected high-speed motor to drive the rod, and non-transferred arc heating, and the atmosphere is controlled by a dynamic sealing method, and the other preparation methods are the same as those in Example 3. The tensile strength, elongation after fracture, compressive elastic modulus and flexural strength are 730.8MPa, 28.6%, 10.8GPa and 1463MPa respectively, and the density reaches 4.89g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 162.3Ω·cm 2 and 7.782×10 5 Ω·cm 2 , indicating that the alloy has good corrosion resistance.
[0035] Comparative Example 1
[0036] A medical titanium alloy, whose alloy composition is Ti-16.5Ta-4.5Nb-4.2Zr-0.0005O, is prepared by EIGA method, and its output power density is 360J / g, atomization pressure is 6MPa, and atomization flow rate is 720Nm 3 / h process, and the powder was obtained by sieving through -270 mesh. 50 and D 90 The alloy solid was printed by laser selective melting with a laser power of 160W, a scanning speed of 2400mm / s, a scanning interval of 0.08mm and a powder thickness of 0.03mm. Its tensile strength, elongation after fracture, compressive elastic modulus and flexural strength were 534MPa, 13.2%, 43.8GPa and 824MPa respectively, and its density reached 4.93g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 63.4Ω·cm 2 and 0.836×10 5 Ω·cm 2 ; After being treated at 750±10℃ / 8h / AC+200±10℃ / 12h / AC, the material was obtained. Its tensile strength, elongation after fracture, compressive elastic modulus and flexural strength are 649MPa, 21.3%, 24.6GPa and 1041MPa respectively, and the density reaches 5.01g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 98.3Ω·cm 2 and 2.139×10 5 Ω·cm 2, indicating the alloy's lower impedance and poorer corrosion resistance.
[0037] Comparative Example 2
[0038] A medical titanium alloy, the alloy composition of which is Ti-14Ta-1Nb-1Zr-0.005O, and the powder is prepared by the EIGA method. The powder making process is as follows: the output power density is 300J / g, the atomization pressure is 8MPa, and the atomization flow rate is 800Nm 3 / h condition, no effective powder was obtained.
[0039] Comparative Example 3
[0040] A medical titanium alloy, the heat treatment process is 800℃ / 8h / AC stabilization treatment, and the rest is performed according to Example 2. The tensile strength, elongation after fracture, compressive elastic modulus and flexural strength of the material before heat treatment are 596.4MPa, 17.5%, 28.4GPa and 892MPa respectively, and the density reaches 4.80g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 85.7Ω·cm 2 and 1.336×10 5 Ω·cm 2 The tensile strength, elongation after fracture, compressive elastic modulus and flexural strength of the heat-treated material are 623.7MPa, 18.6%, 30.2GPa and 965MPa respectively, and the density reaches 4.79g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 87.3Ω·cm 2 and 1.539×10 5 Ω·cm 2 , indicating the alloy's lower impedance and poorer corrosion resistance.
[0041] Comparative Example 4
[0042] A medical titanium alloy, the heat treatment process is 700℃ / 8h / AC stabilization treatment, and the rest is performed according to Example 2. The tensile strength, elongation after fracture, compressive elastic modulus and flexural strength of the material before heat treatment are 596.4MPa, 17.5%, 28.4GPa and 892MPa respectively, and the density reaches 4.80g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 85.7Ω·cm 2 and 1.336×10 5 Ω·cm 2The tensile strength, elongation after fracture, compressive elastic modulus and flexural strength of the heat-treated material are 643.6MPa, 20.7%, 19.8GPa and 965MPa respectively, and the density reaches 4.79g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 95.8Ω·cm 2 and 1.839×10 5 Ω·cm 2 .
[0043] Comparative Example 5
[0044] A medical titanium alloy, the alloy composition of which is Ti-10Ta-1.5Nb-1.5Zr, and the preparation method is the same as that of Example 1. The tensile strength, elongation after fracture, compressive elastic modulus and flexural strength of the material before heat treatment are 598.5MPa, 12.9%, 31.6GPa and 892.3MPa respectively, and the density reaches 4.80g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 76.9Ω·cm 2 and 0.781×10 5 Ω·cm 2 , indicating that the alloy has lower impedance and poorer corrosion resistance; the tensile strength, elongation after fracture, compressive elastic modulus and flexural strength of the material after heat treatment are 673.3MPa, 19.5%, 23.4GPa and 1056MPa respectively, and the density reaches 4.81g / mm 3 The transfer resistance (R1) and membrane resistance (R2) of the equivalent circuit results of the AC impedance simulation in simulated saliva immersion at 37°C were 98.4Ω·cm 2 and 1.274×10 5 Ω·cm 2 , indicating the alloy's lower impedance and poorer corrosion resistance.
[0045] From the results of Comparative Example 1, it can be seen that too high a Ta content will lead to a decrease in the mechanical properties and corrosion resistance of the alloy material. From Comparative Example 2, it can be seen that the preparation process has an important influence on the preparation of medical titanium alloys. From Comparative Examples 3 and 4, too high or too low a heat treatment temperature will lead to a decrease in mechanical properties and corrosion resistance. This may be because too high a temperature causes new defects to occur, while too low a temperature means that the oxide cannot evenly fill the defects. From Comparative Example 5, it can be seen that no oxide is formed in the titanium alloy, the mechanical properties and impedance are reduced, and the corrosion resistance is poor. In combination with Example 2, Comparative Example 1 and Comparative Example 5, titanium alloys of different components use the same heat treatment process, and the changes in mechanical properties, impedance and corrosion resistance are not the same. In short, in this application, a medical titanium alloy with good mechanical properties, low elastic modulus, high impedance and good corrosion resistance is prepared by optimizing the design of components, combining powder making, printing and heat treatment processes, which can be applied to the preparation of a variety of additives.
[0046] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A medical titanium alloy, characterized in that: The raw material components are: Ta 9.5-14.0%, Nb 1-5%, Zr 1-5%, O 0.005-0.05%, and the balance is Ti; The preparation method thereof at least comprises heat treatment after forming; the heat treatment is specifically 750±10℃ / 8h / AC+200±10℃ / 12h / AC stabilization treatment.
2. The medical titanium alloy according to claim 1, characterized in that: The raw material components are: Ta 9.5-14.0%, Nb 1-3%, Zr 1-3%, O 0.005-0.02%, and the balance is Ti.
3. The medical titanium alloy according to claim 2, characterized in that: The raw material components are: Ta 9.5-12.0%, Nb 1-2%, Zr 1-2%, O 0.005-0.01%, and the balance is Ti.
4. A medical titanium alloy additive, characterized in that: The medical titanium alloy is obtained by powdering, 3D printing and heat treatment processes according to any one of claims 1 to 3.
5. The method for preparing the medical titanium alloy additive material according to claim 4, characterized in that: The alloy raw material is obtained by powdering, 3D printing and heat treatment processes; the powdering specifically includes: After the billet for powder making is obtained by the method of melting and casting rods, the powder is obtained by the PREP method or the EIGA method.
6. The preparation method according to claim 5, characterized in that: When the EIGA method is used to prepare the powder, the process is: output power density is 400±20% J / g, atomization pressure is 5±20% MPa, atomization flow rate is 900±20% Nm 3 / h process conditions to produce powder.
7. The preparation method according to claim 5, characterized in that: When the PREP method is used to prepare powder, the powder making equipment uses a direct-connected high-speed motor to drive the rods, non-transferred arc heating, and dynamic sealing to control the atmosphere.
8. The preparation method according to claim 6 or 7, characterized in that: The powder is sieved through a 270-mesh sieve to obtain a powder that can be used for 3D printing. The particle size distribution of the powder is 25≤D 50 ≤60μm, D 90 ≤100μm.
9. The preparation method according to claim 5, characterized in that: The 3D printing specifically includes: preparing by a laser selective melting method, wherein the laser power is 200±20% W, the scanning speed is 2000±20% mm / s, the scanning spacing is 0.03-0.08 mm, and the powder thickness is 0.03-0.08 mm to print out the alloy entity.
10. The preparation method according to claim 5, characterized in that: The heat treatment is specifically 750±10°C / 8h / AC+200±10°C / 12h / AC stabilization treatment.
Citation Information
Patent Citations
Oral implant 3D printing method and oral implant
CN109332698A
Dental implant and preparation method thereof
CN110960725A
Cited By
Ti13Nb14Zr1Cu medical titanium alloy, and preparation method and application thereof
CN122979704A
